Parathyroid imaging: Basic principles and KU Leuven experience: MIBI-dual phase versus MIBI/I-123

Acta Oto-Rhino-Laryngologica Belgica

Volumn 55, Issue 2, 2001, Pages 103-117

  Ceyssens, S ^a   Mortelmans, L ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Gradual subtraction; Hyperparathyroidism; MIBI dual phase; MIBI I 123; Preoperative localisation

Indexed keywords

IODINE 123; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; CONFERENCE PAPER; FEMALE; HUMAN; HYPERPARATHYROIDISM; MAJOR CLINICAL STUDY; MALE; PARATHYROID SCINTISCANNING; PREOPERATIVE EVALUATION; RETROSPECTIVE STUDY; STANDARD;

ADENOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYPERPARATHYROIDISM; HYPERPLASIA; MALE; MIDDLE AGED; PARATHYROID NEOPLASMS; PREOPERATIVE CARE; RADIONUCLIDE IMAGING; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SUBTRACTION TECHNIQUE; TECHNETIUM TC 99M SESTAMIBI;

EID: 0034903148     PISSN: 00016497     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (52)

1. Radiocyanocobalamine (Co57B 12) concentration in the parathyroid glands
2. External parathyroid scanning with Se-75 selenomethionine
3. Localisation of parathyroid adenomas by computer-assisted parathyroid scanning
4. Parathyroid scintigraphy re-visited
5. Selenomethionine scanning for parathyroid localization should be abandoned
6. New perspectives in localising enlarged parathyroids by technetium-thallium subtraction scan
7. Parathyroid imaging
8. Limits to parathyroid imaging with thallium-201 confirmed by tissue uptake and phantom studies
9. Parathyroid imaging - How and when
10. Structural histology correlates with results of thallium 201/technetium 99 parathyroid subtraction scintigraphy
11. 99mTc-sestamibi a new agent for parathyroid imaging
12. Parathyroid imaging with technetium-99m-sestamibi: Preoperative localisation and tissue uptake studies
13. Localisation of parathyroid enlargement: Experience with Tc-99m MIBI and thallium-201 scintigraphy, ultrasonography and computerised tomography
14. 99mTc sestamibi (double phase study)
15. Ultrastructural histology correlates of thallium-201/technetium-99m parathyroid subtraction scintigraphy
16. Effect of mitochondrial and plasma-membrane potentials on accumulation hexakis (2-methoxyisobutylisonitrile) technetium in cultured mouse fibroblasts
17. Parathyroid imaging
18. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium 99m-sestamibi (double phase study)
19. Relative 201-TL and 99m-Tc MIBI uptake in parathyroid adenomas: The effect of cellular type and serum PTH concentrations
20. Preoperative parathyroid localisation: Prospective evaluation of technetium 99m sestamibi
21. Sestamibi parathyroid scintigraphy: A prospective study of 100 patients
22. Is SPECT necessary for accurate detection and localization of parathyroid adenomas using Tc-99m sestamibi?
23. Use of technetium Tc99m sestamibi and iodine I 123 radionuclide scan for preoperative localization of abnormal parathyroid glands in primary hyperparathyroidism
24. Efficient parathyroidectomy after enhanced three-dimensional (SPECT/reprojection) preoperative localisation with Tc-99m-sestamibi and intraoperative hormonal measurements
25. Results of reoperation for persistent and recurrent hyperparathyroidism
26. Primary hyperparathyroidism: A review of the long-term surgical and non-surgical morbidities as a basis for a rational approach to treatment
27. The anatomy of primary hyperparathyroidism
28. Parathyroid scintigraphy
29. Pathology of parathyroid tumors
30. Parathyroid localisation. Clinical review
31. Value of technetium 99m sestamibi iodine 123 imaging in reoperative parathyroid surgery
32. Impact of technetium-99m-sestamibi localisation on operative time and success of operations for primary hyperparathyroidism
33. Secondary hyperparathyroidism: Detection with I-123-Tc-99m-sestamibi subtraction scintigraphy versus US
34. A comparison of 10 MHz ultrasound and 201-thallium/99m-technetium subtraction scanning in primary hyperparathyroidism
35. Efficacy of preoperative diagnostic imaging localisation of technetium-99m sestamibi scintigraphy in hyperparathyroidism
36. Parathyroid imaging with 99m-Tc-sestamibi
37. Prospective comparison of technetium-99m-sestamibi/iodine-123 versus high-resolution ultrasonography for the preoperative localisation of abnormal parathyroid glands in patients with previously unoperated primary hyperparathyroidism
38. The use of preoperative localisation of adenomas of the parathyroid glands by thallium-technetium subtraction scintigraphy, high-resolution ultrasonography and computed tomography
39. Sestamibi parathyroid imaging
40. Prospective comparison of dual-phase technetium-99m-sestamibi scintigraphy and high resolution ultrasonography in the evaluation of abnormal parathyroid glands
41. Tc-99m-sestamibi parathyroid scintigraphy
42. Parathyroid imaging using simultaneous double-window recording of Tc-99m-sestamibi and iodine-123: Comparison with the single tracer technique
43. Technetium-99m-sestamibi imaging before reoperation for primary hyperparathyroidism
44. Parathyroid adenomas: Accurate detection and localisation with Tc-99m-sestamibi SPECT
45. The complementary roles of fast spin-echo MR imaging and double-phase 99m-Tc-sestamibi scintigraphy for localisation of hyperfunctioning parathyroid glands
46. Parathyroid hyperplasia may be missed by double-phase Tc-99m-sestamibi scintigraphy alone
47. Coexistent parathyroid adenomas and Hurthle cell tumors: Failure of full detection by subtraction method
48. Comparison between 99m-Tc-tetrofosmine/pertechnetate subtraction scintigraphy and between 99m-Tc-tetrofosmine SPECT for preoperative localisation of parathyroid adenoma in an endemic goitre area
49. Relation of biochemical, cytologic and morphologic parameters to the result of gammagraphy with technetium 99m sestamibi in primary hyperparathyroidism